Personalize Concerto: A Study Protocol for Optimizing Patient Usability Experience With an eHealth Platform for Embedded, Coordinated and Efficient Healthcare
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Disease
- Sponsor
- Laval University
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Patient Activation
- Last Updated
- 7 years ago
Overview
Brief Summary
The study aims to develop a module of an eHealth platform, do a feasibility study through a pilot cluster randomized control trial and assess the scalability of the solution.
Detailed Description
Multimorbidity increases care needs and primary care use among people with chronic diseases (1). The Concerto Health Program (CHP) has been developed to optimize chronic disease management in primary care services. However, in its current version, the CHP primarily targets clinicians and does not aim to respond directly to the needs of patients and their informal caregivers for chronic disease management . This project aims to develop, implement and evaluate a user-centered, multifunctional and personalized eHealth platform (CONCERTO+) to promote a more active patient role in chronic disease management and decision-making through three phases. For phase1: A first prototype will be developed by the design and technology teams, in close collaboration with researchers, health professionals and patient representatives who will identify the functionalities to include in the CONCERTO+ solution. The Phase 2 of the project will consist in a feasibility study based on a pilot cluster randomized clinical trial (c-RCT) where patients with chronic diseases from a primary healthcare practice will receive CONCERTO+ and be compared to patients from a control practice receiving usual care. For Phase 3, the analysis of CONCERTO+ potential for scaling-up will be done by documenting factors and conditions associated with the sustainability and scaling-up of the solution. To do so, the investigators will conduct: 1) two focus groups with patients and informal caregivers who participated in the study (one with the experimental group and one with the control group, each group gathering between eight and twelve participants); 2) semi-structured individual interviews with health professionals at the two study sites, as well as with health care managers, information officers, and representatives of the Ministry of Health and Social Services.
Investigators
Marie-Pierre Gagnon
Professor
Laval University
Eligibility Criteria
Inclusion Criteria
- •Having one or more targeted chronic diseases (diabetes, hypertension, dyslipidemia)
- •had 3 or more visits in the last 12 months
- •having an interest in health and technologies,
- •be able to read and speak in French
Exclusion Criteria
- •Majors whose incapacity has been recognised judically
Outcomes
Primary Outcomes
Patient Activation
Time Frame: 6 months
The Patient Activation Measure -13 (2) is built on patient knowledge, skills and confidence that are directly targeted by the intervention and is associated to their activation level. Patients who are more activated have better health outcomes. Patients answer to a survey of 13 questions with the following scoring for each answer: Strongly disagree = 1; Disagree = 2; Agree = 3; strongly agree = 4 The score of the activation level obtained (between 0 and 100) shows the degree of ability to manage their health with confidence according to the following scale ranges: 1. Not believing that activation is important (≤ 47) 2. Lack of knowledge or confidence to take action (47.1 - 55.1) 3. Beginning to take action (55.2 - 67) 4. Taking action (≥ 67.1).
Secondary Outcomes
- Process of care(9 months)
- Acceptability(9 months)